Cumberland Pharmaceuticals Q3 2026 Results: Turns Profitable, Net Income $77.8M
Cumberland Pharmaceuticals reported a significant net income of $77.8 million for the quarter ended September 30, 2026, primarily driven by an $81.1 million gain from the disposal of discontinued operations. Total revenue from continuing operations increased to $2.2 million, while the company declared a substantial cash dividend of $22.5 million during the period.
- Key figure
- Net income $77.8M